Trial intelligence / Profile preview

MMR vaccine for prevention of COVID-19 in healthcare workers

PACTR202004693933092Not yet recruiting

Sponsor
Misr University for Science and Technology
Start
Apr 2020
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Randomised trial in coronavirus disease 2019 (COVID-19) comparing MMR vaccine with Placebo (2 arms). Primary endpoint: Serologic evidence of infection. Planned start Apr 2020; status: not yet recruiting.

02

Drugs

M-M-R II
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on PACTR202004693933092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202004693933092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call